science

Constipation Medication Shows Potential in Alleviating Depression-Related Brain Fog

16 Temmuz 2026Science Daily

A constipation medication, prucalopride, has shown potential in alleviating 'brain fog' associated with depression. In a recent clinical trial, participants with a depression history who took prucalopride for a week exhibited improved cognitive functions, including memory and attention, compared to those on a placebo.
The drug operates by targeting serotonin receptors present in both the gut and brain, with no notable side effects reported.
Depression is often accompanied by cognitive challenges, commonly referred to as 'brain fog,' which can significantly impact daily functioning. The exploration of existing medications for new therapeutic uses is a growing trend in psychiatry, especially as mental health issues become increasingly prevalent.
The findings from this trial suggest a promising repurposing of prucalopride, which could provide a dual benefit for individuals struggling with both gastrointestinal issues and cognitive impairments related to depression. The connection between gut health and mental well-being continues to gain traction in scientif…

NewsAI özeti

This article is for informational purposes only and is not intended as medical advice. Please consult a healthcare professional for medical concerns.

Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.

Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.